An interview with Neil

EVOLVA: an Interview with CEO Neil Goldsmith

by Daniela Quaglia published in PLOS Synbio Community


Founded in 2004, Evolva is one of the first synthetic biology companies ever created, and it is a beautiful example of a successful business in our field. Evolva employs more than 175 people around the globe and since 2009 it has been listed on the Swiss Stock Exchange (SIX: EVE). Evolva’s CEO Neil Goldsmith kindly agreed to walk us through the company’s history, goals, and philosophy in a very inspiring interview.

Neil Goldsmith, CEO of Evolva
Neil Goldsmith, CEO of Evolva


A bit of history

At the time in which Evolva was founded people were not speaking much about synthetic biology, at least using this terminology. As Goldsmith points out:

We actually did not know that we were setting up a synthetic biology company because the term was not really in use. At the time we called what we did ‘genetic chemistry’.

Read the full article on the PLOS Blog

Sign up to receive our
Press Releases!

Sign up